Skip to main content
· 5/14/2002

In Re Lorazepam & Clorazepate Antitrust Litigation

Citations

  • 289 F.3d 98
  • 351 U.S. App. D.C. 223
  • 52 Fed. R. Serv. 3d 930
  • 2002 U.S. App. LEXIS 9120
  • 2002 WL 975722

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • noting that “it is understood, if not presumed, that appellate courts will act with cognizance” of the concerns associated with interlocutory appeals
  • holding that “review is limited to issues that relate to class certification”
  • holding 13 in an antitrust class action that “[u]nlike constitutional 14 standing, this court’s jurisdiction does not turn on antitrust 15 standing”
  • justifying “manifestly erroneous” Rule 23(f) ground for review “to avoid a lengthy and costly trial that is for naught once the final judgment is appealed”
  • rejecting challenge to district court’s factual findings and noting that district court could further refine the class as additional facts came to light
  • “[J]urisdiction does not turn on antitrust standing.” (citing Assoc. Gen. Contractors of Cal., Inc., 459 U.S. at 535 n.31)

Source: CourtListener parenthetical corpus (CC0).

Judges: Garland, Ginsburg, Rogers

Read full opinion on CourtListener

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.